Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / ALXN - Alexion: A Good Buy For Long-Term Appreciation


ALXN - Alexion: A Good Buy For Long-Term Appreciation

Alexion Pharmaceuticals (ALXN) is an innovative, commercial-stage pharmaceutical company specializing in therapies for rare, hard-to-treat diseases. It has a market cap of about $29 billion. The stock has not moved much, expecting volatility, since early 2014, but revenue and earnings have risen substantially. Alexion has a strong pipeline. Given its current valuation, I believe that makes it a good investment for anyone with a long-term strategy.

ALXN reached a high price of $208.83 back in July 2015. During this last year, the 52-week low is $92.56, and the high $141.86. It closed on

Read more ...

Stock Information

Company Name: Alexion Pharmaceuticals Inc.
Stock Symbol: ALXN
Market: NASDAQ
Website: alexion.com

Menu

ALXN ALXN Quote ALXN Short ALXN News ALXN Articles ALXN Message Board
Get ALXN Alerts

News, Short Squeeze, Breakout and More Instantly...